Thoenen, Jacob http://orcid.org/0000-0001-5348-3462
Stevens, Kathryn J.
Turmezei, Tom D.
Chaudhari, Akshay
Watkins, Lauren E.
McWalter, Emily J.
Hargreaves, Brian A.
Gold, Garry E.
MacKay, James W.
Kogan, Feliks
Funding for this research was provided by:
National Institutes of Health (R01-EB002524, R02-AR0063643, R01-AR077604, R24-AR062068-07, R00-EB022634)
General Electric
Article History
Received: 4 March 2021
Revised: 22 March 2021
Accepted: 28 April 2021
First Online: 15 May 2021
Declarations
:
: The scientific guarantor of this publication is Dr. Feliks Kogan.
: The authors of this manuscript declare relationships with the following companies: Drs. Gold, MacKay, Hargreaves, Kogan, Chaudhari, and Stevens receive research funding from GE Healthcare, Drs. Gold, Hargreaves, Kogan, and Chaudhari receive research funding from Phillips Healthcare, and Dr. MacKay receives research funding from GlaxoSmithKline. Dr. MacKay is now an employee of AstraZeneca.
: Dr. Jarrett Rosenberg kindly provided statistical advice for this manuscript.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • experimental• performed at one institution